Paper36968140
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
Florian DC and 10 others. Cancer Res Commun, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction. Papers, record 36968140. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968140
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
- PubMed
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Mice | |
| Animals | |
| Bone Marrow | |
| Cytokines | |
| Phenotype | |
| Tumor Microenvironment |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA245134 | NCI NIH HHS | United States | R01CA245134 | PubMed and NIH | NIH RePORTER |
| I01 BX001957 | BLRD VA | United States | I01BX001957 | PubMed and NIH | NIH RePORTER |
| U01 OH012271 | NIOSH CDC HHS | United States | U01OH012271 | PubMed and NIH | NIH RePORTER |
| R01 CA262287 | NCI NIH HHS | United States | R01CA262287 | PubMed and NIH | NIH RePORTER |
| IK6 BX006476 | BLRD VA | United States | IK6BX006476 | PubMed | NIH RePORTER |
| T32 GM007347 | NIGMS NIH HHS | United States | T32GM007347 | PubMed and NIH | NIH RePORTER |
| P30 CA068485 | NCI NIH HHS | United States | P30CA068485 | PubMed and NIH | NIH RePORTER |
| F31 CA257275 | NCI NIH HHS | United States | F31CA257275 | PubMed and NIH | NIH RePORTER |
| T32 GM152284 | NIGMS NIH HHS | United States | T32GM152284 | PubMed | NIH RePORTER |
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 2 | 17763372 | Pathologic fractures correlate with reduced survival in patients with malignant bone disease. | Cancer | 2007 | https://conductscience.org/library/papers/17763372 | PubMed |
| 3 | 33189789 | Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration. | J Control Release | 2021 | https://conductscience.org/library/papers/33189789 | PubMed |
| 4 | 20704976 | Mechanisms of bone metastasis. | Discov Med | 2004 | https://conductscience.org/library/papers/20704976 | PubMed |
| 5 | 31477121 | Surgical stress and cancer progression: the twisted tango. | Mol Cancer | 2019 | https://conductscience.org/library/papers/31477121 | PubMed |
| 6 | 30973611 | Current Landscape of Immunotherapy in Breast Cancer: A Review. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30973611 | PubMed |
| 7 | 18305549 | The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites. | Leukemia | 2008 | https://conductscience.org/library/papers/18305549 | PubMed |
| 8 | 30258983 | Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy. | Adv Biosyst | 2017 | https://conductscience.org/library/papers/30258983 | PubMed |
| 9 | 21832278 | Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. | Blood | 2011 | https://conductscience.org/library/papers/21832278 | PubMed |
| 10 | 25663076 | Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo. | Prostate | 2015 | https://conductscience.org/library/papers/25663076 | PubMed |
| 11 | 12177785 | The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice. | Br J Cancer | 2002 | https://conductscience.org/library/papers/12177785 | PubMed |
| 12 | 32796899 | Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis. | Sci Rep | 2020 | https://conductscience.org/library/papers/32796899 | PubMed |
| 13 | 29204985 | Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow. | J Zhejiang Univ Sci B | 2017 | https://conductscience.org/library/papers/29204985 | PubMed |
| 14 | 34339645 | Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/34339645 | PubMed |
| 15 | 30823602 | The Contribution of the Immune System in Bone Metastasis Pathogenesis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30823602 | PubMed |
| 16 | 23307597 | Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects. | Ann Hematol | 2013 | https://conductscience.org/library/papers/23307597 | PubMed |
| 17 | 32169869 | Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/32169869 | PubMed |
| 18 | 30971820 | Developmental origin, functional maintenance and genetic rescue of osteoclasts. | Nature | 2019 | https://conductscience.org/library/papers/30971820 | PubMed |
| 19 | 30779854 | Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling. | J Bone Miner Res | 2019 | https://conductscience.org/library/papers/30779854 | PubMed |
| 20 | 34831167 | Mechanisms, Diagnosis and Treatment of Bone Metastases. | Cells | 2021 | https://conductscience.org/library/papers/34831167 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902412 | Nanoengineered STING agonists for cancer therapy: toward immunodynamic control. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42902412 | PubMed |
| 42798946 | Analysis of the heterogeneity of the immune microenvironment of bone metastases and new strategies of nanotechnology intervention. | Oncol Rev | 2026 | https://conductscience.org/library/papers/42798946 | PubMed |
| 42198265 | Nanoparticle Strategies for Bone Metastasis Immunotherapy: Targeting, Immune Reprogramming and Combination Therapy. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198265 | PubMed |
| 42146389 | CPT1A loss promotes lung metastasis in immune-competent mice via a mechanism of mtDNA release and chronic activation of STING pathway. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146389 | PubMed |
| 41150754 | Monitoring Pharmacological Treatment of Breast Cancer with MRI. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150754 | PubMed |
| 37753868 | Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing. | Nanoscale | 2023 | https://conductscience.org/library/papers/37753868 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| STING1 | 340061 | PubTator's text mining | https://conductscience.org/library/genes/340061 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36968140
GET https://conductscience.org/api/papers/v1/36968140/references?page=2